PLA2G7 and type 2 diabetes mellitus: A total of 238.4 U/L and 71.7 μg/L were determined as the optimal cut‐off points of Lp‐PLA2 and CTRP‐3 to predict the risk of CVD in T2DM patients, with a sensitivity of 78.45% and 71.61% and a specificity of 94.83% and 79.72%, respectively.